Follow the people · Insider
Eric Bjerkholt
Eric Bjerkholt files insider transactions with the SEC as a chief financial officer of Mirum Pharmaceuticals (MIRM). We hold 7 disclosed purchases and sales filed since 1 March 2006, 3 of them in the last 90 days.
- Files forMIRM
- Disclosed buys and sells7 in all, 3 in the last 90 days
- Last disclosure12 August 2026
Positions held
11 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 11 September 2023 — 11 August 2026Chief Financial Officer · Mirum Pharmaceuticals (MIRM)55 Form 4 lines · source: SEC Form 4
- Filed 3 February 2025 — 9 June 2026Director · Metagenomi (MGX)3 Form 4 lines · source: SEC Form 4
- Filed 5 October 2018 — 9 June 2026Director · Cerus (CERS)26 Form 4 lines · source: SEC Form 4
- Filed 18 May 2023 — 13 May 2026Director · Surrozen, Inc./DE (SRZN)4 Form 4 lines · source: SEC Form 4
- Filed 8 May 2023 — 27 August 2024Director · CalciMedica (CALC)12 Form 4 lines · source: SEC Form 4
- Filed 30 November 2020 — 11 August 2023Chief Financial Officer · Chinook Therapeutics (KDNY)33 Form 4 lines · source: SEC Form 4
- Filed 24 September 2020 — 23 March 2023Director · Graybug Vision (GRAY)6 Form 4 lines · source: SEC Form 4
- Filed 28 April 2017 — 13 October 2020Chief Financial Officer · Aimmune Therapeutics (AIMT)25 Form 4 lines · source: SEC Form 4
- Filed 14 April 2015 — 27 November 2018Director · Corium International (CORI)14 Form 4 lines · source: SEC Form 4
- Filed 13 October 2006 — 30 November 2016EVP, CFO & Corp. Secretary · Sunesis Pharmaceuticals (SNSS)44 Form 4 lines · source: SEC Form 4
- Filed 1 March 2006 — 1 January 2016Director · Stemcells (STEM)13 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,001 shares of Mirum PharmaceuticalsSEC Form 412 August 2026Common Stock · traded 11 August 2026 · filed 12 August 2026
- ▼ sold on the open market 3,124 shares of Mirum PharmaceuticalsSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 1,048 shares of Mirum PharmaceuticalsSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 528 shares of Mirum PharmaceuticalsSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 300 shares of Mirum PharmaceuticalsSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- was granted 21,000 shares of Metagenomi Therapeutics (a derivative holding)SEC Form 411 June 2026Stock Option (Right to Buy) · traded 9 June 2026 · filed 11 June 2026
- ▼ sold on the open market 20,454 shares of CerusSEC Form 411 June 2026Common Stock · traded 9 June 2026 · filed 11 June 2026
- ▼ sold on the open market 2,258 shares of Mirum PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 1,175 shares of Mirum PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 1,567 shares of Mirum PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 8 June 2026 · filed 9 June 2026
- exercised options over 2,393 shares of Mirum PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- exercised options over 2,393 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 49 June 2026Employee Stock Option (right to buy) · traded 9 June 2026 · filed 9 June 2026
- was granted 60,000 shares of CerusSEC Form 42 June 2026Common Stock · traded 2 June 2026 · filed 2 June 2026
- was granted 5,550 shares of Surrozen, Inc./DE (a derivative holding)SEC Form 414 May 2026Director Stock Option (right to buy) · traded 13 May 2026 · filed 14 May 2026
- exercised options over 13,334 shares of Mirum PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- ▼ sold on the open market 7,287 shares of Mirum PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 13,334 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Performance Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 13,334 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 417 March 2026Performance Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 13,334 shares of Mirum PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- ▼ sold on the open market 7,287 shares of Mirum PharmaceuticalsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- was granted 18,140 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 28 January 2026 · filed 30 January 2026
- was granted 11,760 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 28 January 2026 · filed 30 January 2026
- was granted 20,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Performance Restricted Stock Units · traded 28 January 2026 · filed 30 January 2026
- was granted 18,140 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 28 January 2026 · filed 30 January 2026
- was granted 11,760 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 28 January 2026 · filed 30 January 2026
- was granted 20,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 430 January 2026Performance Restricted Stock Units · traded 28 January 2026 · filed 30 January 2026
- exercised options over 2,667 shares of Mirum PharmaceuticalsSEC Form 427 January 2026Common Stock · traded 23 January 2026 · filed 27 January 2026
- ▼ sold on the open market 1,053 shares of Mirum PharmaceuticalsSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- exercised options over 2,667 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 427 January 2026Restricted Stock Units · traded 23 January 2026 · filed 27 January 2026
- exercised options over 2,667 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 427 January 2026Restricted Stock Units · traded 23 January 2026 · filed 27 January 2026
- exercised options over 2,667 shares of Mirum PharmaceuticalsSEC Form 427 January 2026Common Stock · traded 23 January 2026 · filed 27 January 2026
- ▼ sold on the open market 1,053 shares of Mirum PharmaceuticalsSEC Form 427 January 2026Common Stock · traded 26 January 2026 · filed 27 January 2026
- exercised options over 3,334 shares of Mirum PharmaceuticalsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 1,421 shares of Mirum PharmaceuticalsSEC Form 423 January 2026Common Stock · traded 22 January 2026 · filed 23 January 2026
- exercised options over 3,334 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 423 January 2026Restricted Stock Units · traded 21 January 2026 · filed 23 January 2026
- exercised options over 3,334 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 423 January 2026Restricted Stock Units · traded 21 January 2026 · filed 23 January 2026
- exercised options over 3,334 shares of Mirum PharmaceuticalsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 1,421 shares of Mirum PharmaceuticalsSEC Form 423 January 2026Common Stock · traded 22 January 2026 · filed 23 January 2026
- exercised options over 18,333 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 412 September 2025Restricted Stock Units · traded 11 September 2025 · filed 12 September 2025
- exercised options over 18,333 shares of Mirum PharmaceuticalsSEC Form 412 September 2025Common Stock · traded 11 September 2025 · filed 12 September 2025
- ▼ sold on the open market 9,578 shares of Mirum PharmaceuticalsSEC Form 412 September 2025Common Stock · traded 12 September 2025 · filed 12 September 2025
- exercised options over 2,954 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 412 August 2025Employee Stock Option (right to buy) · traded 12 August 2025 · filed 12 August 2025
- ▼ sold on the open market 8,000 shares of Mirum PharmaceuticalsSEC Form 412 August 2025Common Stock · traded 11 August 2025 · filed 12 August 2025
- exercised options over 2,954 shares of Mirum PharmaceuticalsSEC Form 412 August 2025Common Stock · traded 12 August 2025 · filed 12 August 2025
- was granted 8,572 shares of Metagenomi (a derivative holding)SEC Form 412 June 2025Stock Option (Right to Buy) · traded 10 June 2025 · filed 12 June 2025
- was granted 60,000 shares of CerusSEC Form 44 June 2025Common Stock · traded 3 June 2025 · filed 4 June 2025
- was granted 1,333 shares of Surrozen, Inc./DE (a derivative holding)SEC Form 415 May 2025Option (right to buy) · traded 14 May 2025 · filed 15 May 2025
- was granted 42,000 shares of Metagenomi (a derivative holding)SEC Form 45 February 2025Stock Option (Right to Buy) · traded 3 February 2025 · filed 5 February 2025
- exercised options over 2,667 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 427 January 2025Restricted Stock Units · traded 23 January 2025 · filed 27 January 2025
- exercised options over 2,667 shares of Mirum PharmaceuticalsSEC Form 427 January 2025Common Stock · traded 23 January 2025 · filed 27 January 2025
- was granted 40,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 423 January 2025Stock Option (right to buy) · traded 21 January 2025 · filed 23 January 2025
- was granted 10,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 423 January 2025Restricted Stock Units · traded 21 January 2025 · filed 23 January 2025
- ▼ sold on the open market 20,000 shares of CerusSEC Form 416 December 2024Common Stock · traded 12 December 2024 · filed 16 December 2024
- was granted 475 shares of Mirum PharmaceuticalsSEC Form 414 November 2024Common Stock · traded 8 November 2024 · filed 14 November 2024
- exercised options over 18,334 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 412 September 2024Restricted Stock Units · traded 11 September 2024 · filed 12 September 2024
- exercised options over 18,334 shares of Mirum PharmaceuticalsSEC Form 412 September 2024Common Stock · traded 11 September 2024 · filed 12 September 2024
- was granted 10,000 shares of CalciMedica (a derivative holding)SEC Form 428 August 2024Director Stock Option (Right to Buy) · traded 27 August 2024 · filed 28 August 2024
- was granted 40,000 shares of CerusSEC Form 46 June 2024Common Stock · traded 5 June 2024 · filed 6 June 2024
- was granted 1,333 shares of Surrozen, Inc./DE (a derivative holding)SEC Form 46 June 2024Option (right to buy) · traded 5 June 2024 · filed 6 June 2024
- was granted 470 shares of Mirum PharmaceuticalsSEC Form 416 May 2024Common Stock · traded 10 May 2024 · filed 16 May 2024
- was granted 10,000 shares of CalciMedica (a derivative holding)SEC Form 422 April 2024Director Stock Option (Right to Buy) · traded 28 March 2024 · filed 22 April 2024
- ▲ bought on the open market 2,000 shares of Mirum PharmaceuticalsSEC Form 427 March 2024Common Stock · traded 27 March 2024 · filed 27 March 2024
- ▲ bought on the open market 2,000 shares of Mirum PharmaceuticalsSEC Form 418 March 2024Common Stock · traded 18 March 2024 · filed 18 March 2024
- was granted 32,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 425 January 2024Stock Option (right to buy) · traded 23 January 2024 · filed 25 January 2024
- was granted 8,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 425 January 2024Restricted Stock Units · traded 23 January 2024 · filed 25 January 2024
- ▲ bought on the open market 10,000 shares of CerusSEC Form 413 December 2023Common Stock · traded 13 December 2023 · filed 13 December 2023
- was granted 110,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 412 September 2023Stock Option (right to buy) · traded 11 September 2023 · filed 12 September 2023
- was granted 55,000 shares of Mirum Pharmaceuticals (a derivative holding)SEC Form 412 September 2023Restricted Stock Units · traded 11 September 2023 · filed 12 September 2023
- ▲ bought on the open market 10,000 shares of Mirum PharmaceuticalsSEC Form 412 September 2023Common Stock · traded 11 September 2023 · filed 12 September 2023
- ▲ bought on the open market 10,000 shares of CerusSEC Form 423 August 2023Common Stock · traded 21 August 2023 · filed 23 August 2023
- returned to the issuer 144,787 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 21,501 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 88,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 84,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 16,415 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 2,435 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 14,667 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 21,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 8,400 shares of Chinook Therapeutics (a derivative holding)SEC Form 411 August 2023Restricted Stock Units · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 39,371 shares of Chinook TherapeuticsSEC Form 411 August 2023Common Stock · traded 11 August 2023 · filed 11 August 2023
- was granted 20,000 shares of CalciMedica (a derivative holding)SEC Form 428 June 2023Director Stock Option (Right to Buy) · traded 8 May 2023 · filed 28 June 2023
- was granted 40,000 shares of CerusSEC Form 49 June 2023Common Stock · traded 7 June 2023 · filed 9 June 2023
- ▲ bought on the open market 5 shares of CalciMedicaSEC Form 41 June 2023Common Stock · traded 30 May 2023 · filed 1 June 2023
- ▲ bought on the open market 100 shares of CalciMedicaSEC Form 41 June 2023Common Stock · traded 31 May 2023 · filed 1 June 2023
- ▲ bought on the open market 150 shares of CalciMedicaSEC Form 41 June 2023Common Stock · traded 31 May 2023 · filed 1 June 2023
- ▲ bought on the open market 500 shares of CalciMedicaSEC Form 424 May 2023Common Stock · traded 23 May 2023 · filed 24 May 2023
- ▲ bought on the open market 5,000 shares of CerusSEC Form 423 May 2023Common Stock · traded 23 May 2023 · filed 23 May 2023
- ▲ bought on the open market 1 share of CalciMedicaSEC Form 422 May 2023Common Stock · traded 18 May 2023 · filed 22 May 2023
- ▲ bought on the open market 199 shares of CalciMedicaSEC Form 422 May 2023Common Stock · traded 19 May 2023 · filed 22 May 2023
- was granted 20,000 shares of Surrozen, Inc./DE (a derivative holding)SEC Form 419 May 2023Option (right to buy) · traded 18 May 2023 · filed 19 May 2023
- ▲ bought on the open market 800 shares of CalciMedicaSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- ▲ bought on the open market 200 shares of CalciMedicaSEC Form 418 May 2023Common Stock · traded 17 May 2023 · filed 18 May 2023
- ▲ bought on the open market 300 shares of CalciMedicaSEC Form 418 May 2023Common Stock · traded 18 May 2023 · filed 18 May 2023
- returned to the issuer 1,429 shares of CalciMedica (a derivative holding)SEC Form 427 March 2023Restricted Stock Unit · traded 23 March 2023 · filed 27 March 2023
- returned to the issuer 1,429 shares of CalciMedicaSEC Form 427 March 2023Common Stock · traded 23 March 2023 · filed 27 March 2023
- exercised options over 2,435 shares of Chinook Therapeutics (a derivative holding)SEC Form 415 February 2023Restricted Stock Units · traded 10 February 2023 · filed 15 February 2023
- exercised options over 2,435 shares of Chinook TherapeuticsSEC Form 415 February 2023Common Stock · traded 10 February 2023 · filed 15 February 2023
- ▼ sold on the open market 857 shares of Chinook TherapeuticsSEC Form 415 February 2023Common Stock · traded 10 February 2023 · filed 15 February 2023
- exercised options over 7,333 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 February 2023Restricted Stock Unirt · traded 31 January 2023 · filed 2 February 2023
- was granted 84,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 February 2023Stock Option (Right to Buy) · traded 31 January 2023 · filed 2 February 2023
- was granted 21,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 February 2023Restricted Stock Unit · traded 31 January 2023 · filed 2 February 2023
- exercised options over 7,333 shares of Chinook TherapeuticsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 2,891 shares of Chinook TherapeuticsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- exercised options over 16,414 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 December 2022Restricted Stock Units · traded 30 November 2022 · filed 2 December 2022
- exercised options over 16,414 shares of Chinook TherapeuticsSEC Form 42 December 2022Common Stock · traded 30 November 2022 · filed 2 December 2022
- ▼ sold on the open market 5,770 shares of Chinook TherapeuticsSEC Form 42 December 2022Common Stock · traded 1 December 2022 · filed 2 December 2022
- was granted 39,866 shares of Cerus (a derivative holding)SEC Form 43 June 2022Option (Right to Buy) · traded 1 June 2022 · filed 3 June 2022
- was granted 20,454 shares of CerusSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- was granted 20,000 shares of Graybug Vision (a derivative holding)SEC Form 43 June 2022Stock Option (Right to Buy) · traded 2 June 2022 · filed 3 June 2022
- was granted 20,000 shares of Graybug Vision (a derivative holding)SEC Form 43 June 2022Restricted Stock Units · traded 2 June 2022 · filed 3 June 2022
- exercised options over 2,434 shares of Chinook Therapeutics (a derivative holding)SEC Form 414 February 2022Restricted Stock Units (RSU) · traded 10 February 2022 · filed 14 February 2022
- exercised options over 2,434 shares of Chinook TherapeuticsSEC Form 414 February 2022Common Stock · traded 10 February 2022 · filed 14 February 2022
- ▼ sold on the open market 895 shares of Chinook TherapeuticsSEC Form 414 February 2022Common Stock · traded 11 February 2022 · filed 14 February 2022
- was granted 88,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 February 2022Stock Option (right to buy) · traded 31 January 2022 · filed 2 February 2022
- was granted 22,000 shares of Chinook Therapeutics (a derivative holding)SEC Form 42 February 2022Restricted Stock (RSU)(Common Stock) · traded 31 January 2022 · filed 2 February 2022
- exercised options over 16,414 shares of Chinook Therapeutics (a derivative holding)SEC Form 43 December 2021Restricted Stock Units (RSU) · traded 1 December 2021 · filed 3 December 2021
- exercised options over 16,414 shares of Chinook TherapeuticsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- had shares withheld for tax on 5,750 shares of Chinook TherapeuticsSEC Form 43 December 2021Common Stock · traded 1 December 2021 · filed 3 December 2021
- was granted 12,500 shares of Graybug Vision (a derivative holding)SEC Form 44 June 2021Employee Stock Option (Right to Buy) · traded 2 June 2021 · filed 4 June 2021
- exercised options over 13,228 shares of Cerus (a derivative holding)SEC Form 43 June 2021Restricted Stock Unit · traded 1 June 2021 · filed 3 June 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.